Bamco Inc. NY Makes New $1.64 Million Investment in Ionis Pharmaceuticals, Inc. $IONS

The investment firm acquired 25,000 shares of the biotech company's stock in the third quarter.

Mar. 17, 2026 at 7:35am

Got story updates? Submit your updates here. ›

Bamco Inc. NY, an investment management firm, acquired a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) during the third quarter. The firm purchased 25,000 shares of the biotech company's stock, valued at approximately $1.64 million.

Why it matters

This investment by Bamco Inc. NY in Ionis Pharmaceuticals, a leading developer of RNA-targeted therapies, signals confidence in the company's pipeline and future growth potential within the biotechnology industry.

The details

According to Bamco Inc. NY's most recent 13F filing with the Securities and Exchange Commission (SEC), the firm acquired the 25,000 shares of Ionis Pharmaceuticals stock during the third quarter. This new stake represents a fresh investment by Bamco in the biotech company.

  • Bamco Inc. NY acquired the 25,000 shares of Ionis Pharmaceuticals stock during the third quarter.

The players

Bamco Inc. NY

An investment management firm that has acquired a new stake in Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

A biotechnology company focused on the discovery and development of RNA-targeted therapies.

Got photos? Submit your photos here. ›

The takeaway

Bamco Inc. NY's new investment in Ionis Pharmaceuticals reflects the investment firm's confidence in the biotech company's potential for growth and innovation within the RNA-targeted therapy space.